Publications by authors named "Jeffrey Crooke"

Claim this Profile
S
Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists.
Brian C Shook, Devraj Chakravarty, J Kent Barbay, Aihua Wang, Kristi Leonard, Jeffrey Crooke

Bioorg Med Chem Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.
Brian C Shook, Stefanie Rassnick, Nathaniel Wallace, Jeffrey Crooke, Mark Ault

J Med Chem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Brian C Shook, Stefanie Rassnick, Devraj Chakravarty, Nathaniel Wallace, Mark Ault, Jeffrey Crooke

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships.
Ewa Malatynska, Albert Pinhasov, Christopher J Creighton, Jeffrey J Crooke, Allen B Reitz

Neurosci Biobehav Rev· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: technical considerations.
Ewa Malatynska, Albert Pinhasov, Jeffrey J Crooke, Virginia L Smith-Swintosky, Douglas E Brenneman

J Neurosci Methods· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of mRNA coding for alpha-, beta-, and gamma-synuclein in the brains of newborn, juvenile, and adult rats.
Ewa Malatynska, Albert Pinhasov, Jeffrey Crooke, Daniel Horowitz, Douglas E Brenneman

J Mol Neurosci· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diarylacetylene piperidinyl amides as novel anxiolytics.
Cheryl P Kordik, Chi Luo, Maryann Gutherman, Anil H Vaidya, Daniel I Rosenthal, Jeffrey J Crooke

Bioorg Med Chem Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of Submissive Behavior Model for antidepressant drug activity testing: study using a video-tracking system.
Albert Pinhasov, Jeffrey Crooke, Daniel Rosenthal, Douglas Brenneman, Ewa Malatynska

Behav Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of nuclear magnetic resonance-based metabonomics to the dominant-submissive rat behavioral model.
Gregory C Leo, Gary W Caldwell, Jeffrey Crooke, Ewa Malatynska, Carlos Cotto

Anal Biochem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Barry Dubinsky, Anil H Vaidya, Daniel I Rosenthal, Coralie Hochman, Jeffrey J Crooke

J Pharmacol Exp Ther· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis